Senior insider sale
MAZE THERAPEUTICS, INC. — senior position signals high conviction
$2.62M
67.27K shares
What this filing means
KATHIRESAN SEKAR plans to sell 67.27K shares of MAZE THERAPEUTICS, INC. valued at approximately $2.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/16/2026ACC: 0001950047-26-000526
67.27K
Shares to sell
$2.62M
Approx. market value
29.77K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/16/2026
29.77KTotal acquired29.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/16/2026 | Stock Option Exercise Cash | 29.77K | — |
| Total | 29.77K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$425.4K
12/4/2025
—Completed
Units to sell
27.50K
Market value
$984.6K
11/21/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
29.77K
Market value
$1.21M
1/16/2026
Total
Units
67.27K
Value
$2.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/4/2025 | 10K | $425.4K | — | Completed |
11/21/2025 | 27.50K | $984.6K | — | Completed |
| Planned — Approximate Date | ||||
1/16/2026 | 29.77K | $1.21M | NASDAQ | Planned |
| Total | 67.27K | $2.62M | ||